Press Release

Recall two batches of APO-K Slow-Release tablet 600 mg

4 June 2013

The Department of Health (DH) today (June 4) endorsed a licensed drug wholesaler, Hind Wing Co. Ltd. (Hind Wing), to recall two batches of APO-K Slow-Release tablet 600 mg (registration no. HK-36868, batch no. JP0380 and JP0385) from shelves due to potential quality issue.

The DH today received notification from Hind Wing that the product's manufacturer in Canada, Apotex Inc., found the tablet coating solution used for the manufacture of three batches of the APO-K Slow Release tablet may have contained metal particles. Investigation by the manufacturer revealed that the metal particles were confirmed to be stainless steel which came from a piece of mixing equipment used for the preparation of the coating solution.

According to the manufacturer, no APO-K Slow-Release tablet was found to have contained any metal particle so far. However, as a precautionary measure, the manufacturer decided to recall the three affected batches globally.

Based on Hind Wing's record, two of the three affected batches under global recall had been imported into Hong Kong for distribution in 2010. The affected batches were supplied to private doctors, local pharmacies and private hospitals. Hind Wing has informed all affected doctors, pharmacies and hospitals regarding the recall.

So far, the DH has not received any adverse reaction report related to the use of the product. The DH's investigation is continuing.

APO-K Slow-Release 600mg tablet, containing potassium chloride, is an over-the-counter pharmaceutical product used for the prevention of diuretic-induced hypokalaemia.

Hind Wing has set up a hotline, 2566-0562, to answer related enquiries. The DH will closely monitor the recall.

Members of the public who are in doubt should seek advice from their health-care providers.